Altimmune, Inc. (ALT): Price and Financial Metrics

Altimmune, Inc. (ALT): $8.05

0.58 (+7.76%)

POWR Rating

Component Grades

Momentum

C

Stability

F

Sentiment

Quality

D

Add ALT to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#319 of 332

in industry

ALT Price/Volume Stats

Current price $8.05 52-week high $14.84
Prev. close $7.47 52-week low $2.48
Day low $7.52 Volume 4,753,700
Day high $8.42 Avg. volume 3,874,009
50-day MA $7.06 Dividend yield N/A
200-day MA $7.59 Market Cap 572.56M

ALT Stock Price Chart Interactive Chart >


Altimmune, Inc. (ALT) Company Bio


Altimmune, Inc., a clinical stage biopharmaceutical company, focused developing treatments for liver disease, immune modulating therapies, and vaccines. The company develops HepTcell, an immunotherapeutic product candidate that has completed Phase I clinical trial for patients chronically infected with the hepatitis B virus; NasoShield, an anthrax vaccine to provide for protection after a single intranasal administration; NasoVAX, a recombinant intranasal vaccine product candidate; and AdCOVID, a single-dose intranasal vaccine to protect against COVID-19 Its preclinical stage products include ALT-801, a novel peptide-based dual GLP-1/Glucagon receptor agonist for the treatment of non-alcoholic steatohepatitis; and ALT-702, an investigational tumor immunostimulant for treating cancer. The company also develops veterinary product candidates. It has a collaboration with the University of Alabama at Birmingham for the development of AdCOVID. Altimmune, Inc. is headquartered in Gaithersburg, Maryland.


ALT Latest News Stream


Event/Time News Detail
Loading, please wait...

ALT Latest Social Stream


Loading social stream, please wait...

View Full ALT Social Stream

ALT Price Returns

1-mo 18.38%
3-mo 15.99%
6-mo 9.82%
1-year 214.45%
3-year -21.08%
5-year 396.91%
YTD -28.44%
2023 -31.61%
2022 79.59%
2021 -18.79%
2020 496.83%
2019 -8.25%

Continue Researching ALT

Here are a few links from around the web to help you further your research on Altimmune Inc's stock as an investment opportunity:

Altimmune Inc (ALT) Stock Price | Nasdaq
Altimmune Inc (ALT) Stock Quote, History and News - Yahoo Finance
Altimmune Inc (ALT) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!